Intra-Cellular Therapies (Nasdaq: ITCI) is a drug-development company developing novel therapeutics for depression, schizophrania, Parkinson’s disease, Alzheimer’s disease, and other Central Nervous System (CNS) disorders.
Sharon Mates, CEO
3960 Broadway
New York, NY 10032
Tel: 212-923-3344
Fax: 212-923-3388
www.intracellulartherapies.com
PO Box 307
Summit, NJ 07902
+1-856-273-6800
We invest in the most promising early-stage, rapid-growth technology companies in the Mid-Atlantic region.
© 2023 Tech Council Ventures, LLC. All Rights Reserved.
Website designed by Lookit® Design , powered by Lookit® QuikSite.
© 2023 Tech Council Ventures, LLC.
All Rights Reserved.
Website designed by Lookit® Design ,
powered by Lookit® QuikSite.
